Ultrasonic Measurement of the Area of the Anterior Superior Labrum of the Hip Joint for Diagnosis of Labrum Tear

In this study, ultrasound diagnosis was performed for patients with hip joint anterior superior labrum tear, and the final surgical observation was used as the gold standard to evaluate the diagnostic efficacy of ultrasonic measurement of the hip joint anterior superior labrum area in the diagnosis of labrum tear.

Study Overview

• Status: Completed
• Conditions: Acetabular Labrum Tear
• Intervention / Treatment: Diagnostic test: Ultrasonography

Detailed Description

In this study, ultrasound diagnosis was performed for patients with a torn anterior superior labrum of the hip joint, and the final surgical observation was the gold standard. The control group selected patients with non-hip joint reasons to come to the ultrasound department of our hospital for diagnosis at the same time. Both the case group and the control group were included in the study at a rate of 1.1 times. This study plans to include 149 cases in the case group and 297 cases in the control group. This study was used to evaluate the diagnostic efficacy of ultrasonic measurement of the area of the anterior superior labrum of the hip in the diagnosis of labrum tears.

• Study Type: Observational
• Enrollment (Actual): 160

Contacts and Locations

Study Locations

• China
  • Beijing
    • Beijing, Beijing, China
      • Department of Ultrasound Diagnosis, Peking University Third Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Case group: Outpatient Department of Sports Medicine, Peking University Third Hospital, clinically diagnosed patients with hip joint labrum tear, preoperative ultrasound examination.

Control group: Patients who came to our hospital's ultrasound department at the same time for non-hip joint reasons matched by age, gender and case group.

Description

Inclusion Criteria:

Case group inclusion criteria (1) Age is greater than or equal to 18 years old (2) Patients with preoperative ultrasound examination for clinically planned hip joint anterior superior labrum tear (3) The patient can understand and sign the informed consent form Control group inclusion criteria

1. Age is greater than or equal to 18 years old
2. Patients who come to the ultrasound department of our hospital for treatment of non-hip joints at the same time
3. The patient can understand and sign the informed consent form

Exclusion Criteria:

Case group exclusion criteria

1. Mental conditions are not allowed
2. Adhesives that are allergic to any known Control group exclusion criteria

(1) Mental conditions are not allowed (2) Adhesives that are allergic to any known (3) Past and current diseases of other hip joint diseases

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
acetabular labrum tears; Patients with clinically diagnosed acetabular labrum tears	Diagnostic test: Ultrasonography; Patient undergoes diagnostic ultrasound examination
Patients with non-hip injuries; For non-hip joint reasons, come to the ultrasound department of our hospital to diagnose patients at the same time, and exclude other past and current hip diseases	Diagnostic test: Ultrasonography; Patient undergoes diagnostic ultrasound examination

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Ultrasound diagnosis result image	Ultrasound diagnosis as hip joint anterior superior labrum tear	ultrasound diagnosis were preformed with hip arthroscopy at the same 1 day visiting time point

Collaborators and Investigators

• Sponsor: Peking University Third Hospital

Study record dates

Study Major Dates

• Study Start (Actual): July 29, 2018
• Primary Completion (Actual): December 14, 2019
• Study Completion (Actual): February 5, 2020

Study Registration Dates

• First Submitted: June 27, 2021
• First Submitted That Met QC Criteria: July 7, 2021
• First Posted (Actual): July 8, 2021

Study Record Updates

• Last Update Posted (Actual): July 8, 2021
• Last Update Submitted That Met QC Criteria: July 7, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: M2018106

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No